Literature DB >> 17018251

Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients.

H Myoung1, M-J Kim, J-H Lee, Y-J Ok, J-Y Paeng, P-Y Yun.   

Abstract

The purposes of this study were to examine the correlations between proliferation markers and survival rate in oral squamous cell carcinoma (OSCC) patients, and to evaluate the efficacy of proliferation markers in predicting lymph node metastasis. The patients' age, gender, T score, clinical stage, PCNA and Ki-67 index were analysed. Univariate analysis showed that T score had a significant influence on survival, and stage 4 group had a significantly lower survival rate. Lymph node metastasis was also a significant predictor of survival. Using a cut-off point of 25%, those patients with lower Ki-67 scores had survival advantage over those with higher Ki-67 scores. PCNA did not show any differences in survival with a cut-off point of 50%. Ki-67 and PCNA were significantly higher in the primary tumours associated with lymph node metastasis (pN+) than in those without lymph node metastasis (pN0). Multivariate analysis showed that clinical stage and Ki-67 were independent prognostic factors for survival in OSCC patients. From this result, it can be postulated that the cancer staging based on the TNM stage was a powerful prognostic variable and Ki-67 had a significant effect on the cumulative survival rate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17018251     DOI: 10.1016/j.ijom.2006.07.016

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  23 in total

1.  Histological and immunohistochemical evaluation of new epithelium after removal of oral leukoplakia with Nd:YAG laser treatment.

Authors:  Lucio Montebugnoli; Francesca Frini; Davide Bartolomeo Gissi; Andrea Gabusi; Fabio Cervellati; Maria Pia Foschini; Claudio Marchetti
Journal:  Lasers Med Sci       Date:  2011-06-18       Impact factor: 3.161

2.  Anti-tumor effect of the mammalian target of rapamycin inhibitor everolimus in oral squamous cell carcinoma.

Authors:  Tomofumi Naruse; Souichi Yanamoto; Shin-ichi Yamada; Satoshi Rokutanda; Akiko Kawakita; Goro Kawasaki; Masahiro Umeda
Journal:  Pathol Oncol Res       Date:  2015-02-15       Impact factor: 3.201

3.  Efficacy of quercetin against chemically induced murine oral squamous cell carcinoma.

Authors:  Daniel Droguett; Christian Castillo; Elba Leiva; Cristina Theoduloz; Guillermo Schmeda-Hirschmann; Ulrike Kemmerling
Journal:  Oncol Lett       Date:  2015-08-12       Impact factor: 2.967

4.  Prognostic value of proliferating cell nuclear antigen in parotid gland cancer.

Authors:  Markus Stenner; Ariane Demgensky; Christoph Molls; Aline Hardt; Jan C Luers; Maria Grosheva; Christian U Huebbers; Jens P Klussmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-27       Impact factor: 2.503

5.  CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.

Authors:  Henning Hanken; Alexander Gröbe; Georg Cachovan; Ralf Smeets; Ronald Simon; Guido Sauter; Max Heiland; Marco Blessmann
Journal:  Clin Oral Investig       Date:  2013-03-15       Impact factor: 3.573

6.  Equating salivary lactate dehydrogenase (LDH) with LDH-5 expression in patients with oral squamous cell carcinoma: An insight into metabolic reprogramming of cancer cell as a predictor of aggressive phenotype.

Authors:  Tajindra Singh Saluja; Anita Spadigam; Anita Dhupar; Shaheen Syed
Journal:  Tumour Biol       Date:  2015-11-15

7.  High-level β1-integrin expression in a subpopulation of highly tumorigenic oral cancer cells.

Authors:  Hsiang-Chun Lin; Chao-Liang Wu; Yuh-Ling Chen; Jehn-Shyun Huang; Tung-Yiu Wong; Kuo Yuan
Journal:  Clin Oral Investig       Date:  2013-08-25       Impact factor: 3.573

8.  High expressions of histone methylation- and phosphorylation-related proteins are associated with prognosis of oral squamous cell carcinoma in male population of Taiwan.

Authors:  Jen-Hao Chen; Kun-Tu Yeh; Yu-Min Yang; Jan-Gowth Chang; Huey-Er Lee; Shih-Ya Hung
Journal:  Med Oncol       Date:  2013-03-16       Impact factor: 3.064

9.  Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signals.

Authors:  H-M Yun; J H Oh; J-H Shim; J O Ban; K-R Park; J-H Kim; D H Lee; J-W Kang; Y H Park; D Yu; Y Kim; S B Han; D-Y Yoon; J T Hong
Journal:  Cell Death Dis       Date:  2013-05-23       Impact factor: 8.469

10.  Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors.

Authors:  Ronell Bologna-Molina; Adalberto Mosqueda-Taylor; Nelly Molina-Frechero; Ana-Dolores Mori-Estevez; Guillermo Sánchez-Acuña
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.